Detalles de la búsqueda
1.
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood;
140(4): 349-358, 2022 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316325
2.
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry study.
Haematologica;
109(2): 431-443, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37646665
3.
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
Ann Hematol;
103(5): 1587-1599, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194088
4.
Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantation.
Am J Hematol;
2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38742955
5.
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease.
J Transl Med;
21(1): 837, 2023 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37990219
6.
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Blood;
137(22): 3093-3104, 2021 06 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33598693
7.
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Blood;
137(19): 2646-2656, 2021 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33512419
8.
Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients less than 60 years of age: a prospective phase II study
Haematologica;
2023 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941409
9.
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Blood;
136(26): 3041-3050, 2020 12 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33367545
10.
Outcomes of second allogeneic stem cell transplantation and anti-relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis.
Hematol Oncol;
40(4): 763-776, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35368106
11.
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Am J Hematol;
97(8): 1023-1034, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35617104
12.
"SpezPat"- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians' understanding of non-small cell lung cancer patients' end-of-life decisions.
BMC Palliat Care;
21(1): 167, 2022 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36167565
13.
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Blood;
133(8): 840-851, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30563875
14.
Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma-data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin's Lymphoma Study Group).
Ann Hematol;
100(4): 1031-1038, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33242101
15.
Patterns of Late Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with T-Cell Prolymphocytic Leukemia.
Acta Haematol;
144(1): 105-110, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32259827
16.
Cytokine adsorption therapy in lymphoma-associated hemophagocytic lymphohistiocytosis and allogeneic stem cell transplantation.
J Artif Organs;
24(3): 402-406, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33459910
17.
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT.
Br J Haematol;
190(3): 437-441, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32108327
18.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet;
394(10216): 2271-2281, 2019 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31868632
19.
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party.
Haematologica;
105(7): 1977-1983, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601686
20.
Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia.
Br J Haematol;
185(4): 725-732, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30820933